TONY DONATO

Professor

Internal Medicine

RESEARCH INTERESTS

Dr. Donato's research program spans the full translational spectrum, from cultured human and rodent cells to intact arteries to studies in older adults, unified by a central question: what drives the loss of arterial function with age, and how can it be prevented or reversed. Early in his career he refined a minimally invasive method to sample vascular endothelial cells directly from human subjects, providing some of the first direct evidence of age-related endothelial oxidative stress and its links to NF-kB activation, SIRT-1 signaling, and altered nitric oxide bioavailability. His laboratory has since defined how caloric restriction, habitual aerobic exercise, rapamycin, and AMPK activation protect the aging vasculature, and has identified novel mechanisms of arterial aging including telomere uncapping, endothelial microRNA dysregulation, and cellular senescence. More recent work extends to the interface between the vasculature and the immune system, testing the role of T cells in age-related vascular dysfunction, and to the contribution of genomic instability to senescence. In parallel, he has applied this vascular expertise to rare disease, partnering with rheumatology to characterize and treat the vasculopathy of systemic sclerosis, including studies of tetrahydrobiopterin to improve peripheral vascular function. His group employs a broad methodological toolkit, including in vivo and ex vivo measures of arterial function, pressure myography, chromatin immunoprecipitation, direct measurement of reactive oxygen species and nitric oxide in arteries, and CRISPR/Cas9 mouse models.

Building on this foundation, the laboratory's current emphasis is anti-aging drug development. Active programs include NAMPT activators that restore NAD+ through the salvage pathway, novel senolytics that clear senescent cells, and senomorphics that suppress the pro-inflammatory senescence-associated secretory phenotype. His recent NIH-funded work examines the interactions among the endothelium, the immune system, genomic instability, and cellular senescence in the loss of arterial function with age.

GRANTS

  • EXTERNAL GRANT OR CONTRACT
    THE ROLE OF THE HAS2 AND THE ENDOTHELIAL GLYCOCALYX IN AGE-ASSOCIATED VASCULAR DYSFUNCTION
    1 Jul 2023 - 30 Jun 2024
  • EXTERNAL GRANT OR CONTRACT
    INTEGRATIVE MECHANISMS OF VASCULAR AGING RESUBMISSION
    15 Apr 2023 - 31 Dec 2027
  • EXTERNAL GRANT OR CONTRACT
    SAM BLOOM FELLOWSHIP F31 - TELOMERE UNCAPPING AS A NOVEL MECHANISM FOR ENDOTHELIAL CELL SENESCENCE AND AGE-RELATED ARTERIAL DYSFUNCTION
    1 Feb 2023 - 31 Jan 2024
  • EXTERNAL GRANT OR CONTRACT
    IMPROVING HEALTHSPAN THROUGH DISCOVERY OF POTENT NAMPT ACTIVATORS FROM A DNA-ENCODED LIBRARY
    5 Sep 2022 - 31 Aug 2025
  • EXTERNAL GRANT OR CONTRACT
    IPA VENKETASWARA FY22 TN
    1 Apr 2022 - 30 Sep 2023
  • EXTERNAL GRANT OR CONTRACT
    IMPACT OF T CELLS ON AGE-RELATED VASCULAR DYSFUNCTION: A TRANSLATIONAL APPROACH
    1 Sep 2020 - 31 Jan 2025
  • EXTERNAL GRANT OR CONTRACT
    IMPACT OF T CELLS ON AGE-RELATED VASCULAR DYSFUNCTION: A TRANSLATIONAL APPROACH
    15 Apr 2019 - 31 Jan 2025
  • EXTERNAL GRANT OR CONTRACT
    ATM STUDY
    RECURSION PHARMACEUTICALS LLC3 Jan 2018 - 31 Dec 2019
    RECURSION PHARMACEUTICALS LLC
  • EXTERNAL GRANT OR CONTRACT
    IDENTIFICATION OF SENOLYTICS
    RECURSION PHARMACEUTICALS LLC1 Jan 2018 - 31 Dec 2022
    RECURSION PHARMACEUTICALS LLC
  • EXTERNAL GRANT OR CONTRACT
    ROLE OF HYALURONAN
    NIH NATL CTR FOR COMPLMT & INT1 Jan 2018 - 31 Dec 2020
    NIH NATL CTR FOR COMPLMT & INT
  • FELLOWSHIP OR RESIDENCY
    IPA HO
    VA SALT LAKE CITY HEALTH CARE9 Jan 2017 - 31 Dec 2018
    VA SALT LAKE CITY HEALTH CARE
  • EXTERNAL GRANT OR CONTRACT
    TVP SERVICE CONTRACT
    RECURSION PHARMACEUTICALS LLC1 Jan 2017 - 31 Dec 2018
    RECURSION PHARMACEUTICALS LLC
  • EXTERNAL GRANT OR CONTRACT
    R01: TELOMERE UNCAPPING
    NIH NATIONAL INSTITUTE ON AGIN9 Jan 2016 - 31 Dec 2022
    NIH NATIONAL INSTITUTE ON AGIN
  • FELLOWSHIP OR RESIDENCY
    IPA GATES
    VA SALT LAKE CITY HEALTH CARE8 Jan 2016 - 31 Dec 2017
    VA SALT LAKE CITY HEALTH CARE
  • EXTERNAL GRANT OR CONTRACT
    SENOLYTICS (RECURSION PHARMA)
    RECURSION PHARMACEUTICALS LLC1 Jan 2016 - 31 Dec 2017
    RECURSION PHARMACEUTICALS LLC
  • FELLOWSHIP OR RESIDENCY
    IPA HENSON
    VA SALT LAKE CITY HEALTH CARE9 Jan 2015 - 31 Dec 2017
    VA SALT LAKE CITY HEALTH CARE
  • EXTERNAL GRANT OR CONTRACT
    MTOR AND ARTERIAL AGING
    AMERICAN HEART ASSN WSTRN STAT7 Jan 2015 - 31 Dec 2016
    AMERICAN HEART ASSN WSTRN STAT
  • EXTERNAL GRANT OR CONTRACT
    NITRIC OXIDE COUPLING AND BH4
    FLIGHT ATTENDANT MEDICAL RESEA7 Jan 2015 - 31 Dec 2020
    FLIGHT ATTENDANT MEDICAL RESEA
  • FELLOWSHIP OR RESIDENCY
    IPA HO HUYNH
    VA SALT LAKE CITY HEALTH CARE1 Jan 2015 - 31 Dec 2017
    VA SALT LAKE CITY HEALTH CARE
  • FELLOWSHIP OR RESIDENCY
    IPA HOLMES
    VA SALT LAKE CITY HEALTH CARE1 Jan 2015 - 31 Dec 2015
    VA SALT LAKE CITY HEALTH CARE
  • FELLOWSHIP OR RESIDENCY
    IPA DANIEL MACHIN
    VA SALT LAKE CITY HEALTH CARE11 Jan 2014 - 31 Dec 2015
    VA SALT LAKE CITY HEALTH CARE
  • FELLOWSHIP OR RESIDENCY
    IPA GRANT HENSON
    VA SALT LAKE CITY HEALTH CARE9 Jan 2014 - 31 Dec 2015
    VA SALT LAKE CITY HEALTH CARE
  • FELLOWSHIP OR RESIDENCY
    IPA KELLY REIHL
    VA SALT LAKE CITY HEALTH CARE9 Jan 2014 - 31 Dec 2015
    VA SALT LAKE CITY HEALTH CARE
  • FELLOWSHIP OR RESIDENCY
    IPA SUGATA HAZRA
    VA SALT LAKE CITY HEALTH CARE9 Jan 2014 - 31 Dec 2015
    VA SALT LAKE CITY HEALTH CARE
  • EXTERNAL GRANT OR CONTRACT
    ENDOTHEIAL ACTIVATION NAMPT
    NIH NATIONAL INSTITUTE ON AGIN4 Jan 2014 - 31 Dec 2019
    NIH NATIONAL INSTITUTE ON AGIN